financetom
Business
financetom
/
Business
/
Summit Therapeutics Insider Bought Shares Worth $375,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Summit Therapeutics Insider Bought Shares Worth $375,000, According to a Recent SEC Filing
Mar 28, 2024 6:42 AM

09:24 AM EDT, 03/28/2024 (MT Newswires) -- Ankur Dhingra, Chief Financial Officer, on March 26, 2024, executed a purchase for 100,000 shares in Summit Therapeutics ( SMMT ) for $375,000. Following the Form 4 filing with the SEC, Dhingra has control over a total of 354,958 shares of the company, with 354,958 shares controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1599298/000159929824000046/xslF345X03/wk-form4_1711585608.xml

Price: 4.05, Change: +0.3, Percent Change: +8

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Stellantis is in
Stellantis is in "very productive exchange of ideas" with U.S. on tariffs, CEO says
Sep 11, 2025
MILAN, Sept 11 (Reuters) - Stellantis ( STLA ) is in a very productive exchange of ideas with the U.S. administration on tariffs, Chief Executive Antonio Filosa said on Thursday adding the level of inventories for the automaker was now very healthy. ...
GE Vernova to Sell Proficy Software Business to TPG for $600 Million
GE Vernova to Sell Proficy Software Business to TPG for $600 Million
Sep 11, 2025
09:23 AM EDT, 09/11/2025 (MT Newswires) -- GE Vernova ( GEV ) and TPG (TPG) said Thursday they have signed a binding agreement under which TPG will buy GE Vernova's ( GEV ) Proficy manufacturing software business for $600 million. GE Vernova ( GEV ) may get additional sale proceeds depending on several outcomes and conditions, the companies said. TPG...
Form 8.3 - NCC group plc
Form 8.3 - NCC group plc
Sep 11, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: First Trust Advisors L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Sellas Life Sciences to Receive $23.6 Million From Exercise of Warrants
Sellas Life Sciences to Receive $23.6 Million From Exercise of Warrants
Sep 11, 2025
09:24 AM EDT, 09/11/2025 (MT Newswires) -- Sellas Life Sciences Group ( SLS ) said Thursday it will receive gross proceeds of about $23.6 million from the exercise of existing warrants held by an institutional investor. In consideration for the exercise of the warrants, the investor will receive new unregistered warrants to buy up to about 19.7 million shares and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved